title: HGV infection in a cohort of patients with chronic active hepatitis HCV related.
authors.forename: F
authors.initials: F
authors.lastname: Capra
authors.forename: G B
authors.initials: GB
authors.lastname: Gabrielli
authors.forename: E
authors.initials: E
authors.lastname: De Maria
authors.forename: S
authors.initials: S
authors.lastname: Squarzoni
authors.forename: R
authors.initials: R
authors.lastname: Dagradi
authors.forename: L
authors.initials: L
authors.lastname: Dolci
authors.forename: M
authors.initials: M
authors.lastname: Casarili
authors.forename: R
authors.initials: R
authors.lastname: Colombari
authors.forename: R
authors.initials: R
authors.lastname: Corrocher
authors.forename: G
authors.initials: G
authors.lastname: De Sandre
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D005260:Female; D018067:Flaviviridae / Q000235:genetics*; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006525:Hepatitis, Viral, Human / Q000150:complications* / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins